05.24.22 -- Embrace A 360-Degree Approach To Biopharmaceutical Testing Services

A 360-degree approach entails full CMC development and analytical release testing in support of biopharmaceutical products in development and in clinical trials — all from one partner.

For small biopharma businesses, it is nearly impossible to manage every aspect of the development process in-house. Outsourcing provides the flexibility to change capacity and adjust timings.

Learning more about spray drying as well as two case studies detailing its success serves as a critical tool in developing innovative and effective lung cancer therapies.

Growing complexity and risks in drug development and supply have implications for outsourcing models. See how to structure and manage CDMO partnerships for a future filled with uncertainty and disruption.

This white paper discusses the importance of understanding how critical process parameters can impact a product’s critical quality attributes and how a systematic approach with validated SPR assays can help in this respect.

In recent years, biopharmaceutical research processes have demonstrated major improvements in the quality and recovery of mAbs, which to an extent have been associated with culturing the expressing cell lines at high cell densities. This work has generated a great challenge in cell clarification, sterilization, and further downstream processing. These processes must remove large amounts of biomass and increased levels of contaminating cell debris generated during cell culture and harvesting.

Improve data integrity and quality, ensure IP protection, increase efficiency and collaboration, and enable faster and better decision-making.